Andover-based BIOQUELL’s HPV decontamination technology was one of the first technologies to be reviewed by the RRP. Promotion to RRP Category One status means that: ‘Basic research and development, validation and recent in use evaluations have shown benefits that should be available to NHS bodies to include as appropriate in their cleaning, hygiene or infection control protocols.’
To date the RRP has reviewed 42 products or technologies to combat ‘superbugs’ in the ‘Cleaning, Disinfection and Decontamination’ category and has awarded Category One status to only two, one of which is BIOQUELL.
BIOQUELL’s technology is the first product to be promoted to a new category by the RRP, which the company believes was strongly supported the quality and volume of scientific efficacy data it provided.
Nick Adams, chief executive of BIOQUELL, said: ‘Clostridium difficile, MRSA and other ‘superbugs’ remain a real, increasing and sensitive problem for hospitals in the NHS and around the world, as was underscored by the prime minister’s announcement of a deep-clean for every NHS hospital last month. Further, there have been a number of recent reports highlighting the major clinical issues caused by C.diff in hospitals.
‘Despite the sensitivity of these problems, we are pleased that BIOQUELL is being asked to help more and more NHS hospitals combat Clostridium difficile. We are also delighted that the top